Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

AURELIA trial, palliative chemotherapy with bevacizumab in resistant, recurrent ovarian cancer

Dr Gunnar Kristensen – Norwegian Radium Hospital, Oslo, Norway
AURELIA trial, palliative chemotherapy with bevacizumab in resistant, recurrent ovarian cancer ( Dr Gunnar Kristensen – Norwegian Radium Hospital, Oslo, Norway )
30 Oct 2012

The Cancer Genome Atlas and high grade serous ovarian cancer

Dr Andrew Berchuck – Duke University Medical Center, Durham, USA
The Cancer Genome Atlas and high grade serous ovarian cancer ( Dr Andrew Berchuck – Duke University Medical Center, Durham, USA )
30 Oct 2012

Benefits of nomogram versus staging in cervical cancer

Dr Stephen Polterauer – Medical University of Vienna, Austria
Benefits of nomogram versus staging in cervical cancer ( Dr Stephen Polterauer – Medical University of Vienna, Austria )
30 Oct 2012

Gestational trophoblastic disease tumours in high risk patients

Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK
Gestational trophoblastic disease tumours in high risk patients ( Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK )
30 Oct 2012

Late effects of treatment in gynaecological cancers

Dr Remi Nout – Leiden University Medical Center, Netherlands
Late effects of treatment in gynaecological cancers ( Dr Remi Nout – Leiden University Medical Center, Netherlands )
30 Oct 2012

Staging in endometrial cancer and sentinel node mapping

Dr Charles Levenback – MD Anderson Cancer Center, Houston, TX, USA
Staging in endometrial cancer and sentinel node mapping ( Dr Charles Levenback – MD Anderson Cancer Center, Houston, TX, USA )
30 Oct 2012

OCTAVIA trial: bevacizumab and paclitaxel treatment for ovarian cancer

Dr Antonio Gonzalez-Martin – MD Anderson Cancer Center, Madrid, Spain
OCTAVIA trial: bevacizumab and paclitaxel treatment for ovarian cancer ( Dr Antonio Gonzalez-Martin – MD Anderson Cancer Center, Madrid, Spain )
30 Oct 2012

State of PARP inhibitors and anti-angiogenics

Prof Stan Kaye – Royal Marsden Hospital, London, UK
State of PARP inhibitors and anti-angiogenics ( Prof Stan Kaye – Royal Marsden Hospital, London, UK )
29 Oct 2012

Study of ovarian cancer and endometriosis sub-fertility

Prof Curt Burger – Erasmus University, Rotterdam, Netherlands
Study of ovarian cancer and endometriosis sub-fertility ( Prof Curt Burger – Erasmus University, Rotterdam, Netherlands )
29 Oct 2012

New therapies to treat advanced endometrial cancer

Prof Gini Fleming – University of Chicago Medical Center, Illinois, USA
New therapies to treat advanced endometrial cancer ( Prof Gini Fleming – University of Chicago Medical Center, Illinois, USA )
29 Oct 2012

Defining and advancing individualised medicine

Prof Anil Sood – MD Anderson Cancer Centre, Houston, USA
Defining and advancing individualised medicine ( Prof Anil Sood – MD Anderson Cancer Centre, Houston, USA )
29 Oct 2012

Effects of early ovarian cancer screening

Dr Ed Pavlik – University of Kentucky, Lexington, USA
Effects of early ovarian cancer screening ( Dr Ed Pavlik – University of Kentucky, Lexington, USA )
29 Oct 2012